Abstract:BACKGROUND: Understanding the association of acute pain intensity and opioid consumption after cardiac surgery with chronic postsurgical pain (CPSP) can facilitate implementation of personalized prevention measures to improve outcomes. The objectives were to (1) examine acute pain intensity and daily mg morphine equivalent dose (MME/day) trajectories after cardiac surgery, (2) identify factors associated with pain intensity and opioid consumption trajectories, and (3) assess whether pain intensity and opioid consumption trajectories are risk factors for CPSP. METHODS: Prospective observational cohort study design conducted between August 2012 and June 2020 with 1-year follow-up. A total of 1115 adults undergoing cardiac surgery were recruited from the preoperative clinic. Of the 959 participants included in the analyses, 573 completed the 1-year follow-up. Main outcomes were pain intensity scores and MME/day consumption over the first 6 postoperative days (PODs) analyzed using latent growth mixture modeling (GMM). Secondary outcome was 12-month CPSP status. RESULTS: Participants were mostly male (76%), with a mean age of 61 ± 13 years. Three distinct linear acute postoperative pain intensity trajectories were identified: “initially moderate pain intensity remaining moderate” (n = 62), “initially mild pain intensity remaining mild” (n = 221), and “initially moderate pain intensity decreasing to mild” (n = 251). Age, sex, emotional distress in response to bodily sensations, and sensitivity to pain traumatization were significantly associated with pain intensity trajectories. Three distinct opioid consumption trajectories were identified on the log MME/day: “initially high level of MME/day gradually decreasing” (n = 89), “initially low level of MME/day remaining low” (n = 108), and “initially moderate level of MME/day decreasing to low” (n = 329). Age and emotional distress in response to bodily sensations were associated with trajectory membership. Individuals in the “initially mild pain intensity remaining mild” trajectory were less likely than those in the “initially moderate pain intensity remaining moderate” trajectory to report CPSP (odds ratio [95% confidence interval, CI], 0.23 [0.06–0.88]). No significant associations were observed between opioid consumption trajectory membership and CPSP status (odds ratio [95% CI], 0.84 [0.28–2.54] and 0.95 [0.22–4.13]). CONCLUSIONS: Those with moderate pain intensity right after surgery are more likely to develop CPSP suggesting that those patients should be flagged early on in their postoperative recovery to attempt to alter their trajectory and prevent CPSP. Emotional distress in response to bodily sensations is the only consistent modifiable factor associated with both pain and opioid trajectories.

Predictive factors for sleep apnoea in patients on opioids for chronic pain

Pathogenesis of sleep disordered breathing in the setting of opioid use: A multiple mediation analysis using physiology

The effect of acute exposure to morphine on breathing variability and cardiopulmonary coupling in men with obstructive sleep apnea: A randomized controlled trial.

The effect of acute morphine on obstructive sleep apnoea: a randomised double-blind placebo-controlled crossover trial

Non-analgesic effects of opioids: opioids' effects on sleep (including sleep apnea).

Sleep behavior traits and associations with opioid-related adverse events: a cohort study

Prevalence and characteristics of pain in moderate-to-severe obstructive sleep apnea patients and effect of CPAP treatment

1165 A Challenging Case of Chronic Fentanyl Use Inducing Central Sleep Apnea After Tracheostomy

The Influence of Acute Morphine Use on Obstructive Sleep Apnea: A Systematic Review and Meta‐analysis

0908 Pain in OSA Patients Is Modulated by Chronic Pain History and Sex

Comparison of Awake Respiratory Control Versus Sleep Obstructive Sleep Apnea Endotypes

0986 Inter-Individual Differences in Sleep Architecture of Patients Receiving Methadone for Opioid Use Disorder

Intrathecal morphine and sleep apnoea severity in patients undergoing hip arthroplasty: a randomised, controlled, triple-blinded trial

Continuous Positive Airway Pressure Mitigates Opioid-induced Worsening of Sleep-disordered Breathing Early after Bariatric Surgery

0911 Characterizing Sleep, Pain, and Opioid Craving in People with Chronic Low Back Pain on Long Term Opioid Therapy

Sleep-related impairment among people who use opioids: The critical role of structural vulnerability

0495 Association of Cannabis Use and Symptoms Among Patients with Obstructive Sleep Apnea

A Prospective Cohort Study of Acute Pain and In-Hospital Opioid Consumption After Cardiac Surgery: Associations With Psychological and Medical Factors and Chronic Postsurgical Pain

USE OF THE EPWORTH SLEEPINESS SCALE, THE NOSAS, AND THE STOP-BANG QUESTIONNAIRE TO IDENTIFY PATIENTS WITH MODERATE-TO-SEVERE OBSTRUCTIVE SLEEP APNEA

0467 Effect of Hypoxia on Ventilatory Responsiveness in Opioid-Related Sleep Disordered Breathing

Perioperative considerations in the management of obstructive sleep apnoea